CELLECTIS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.345 EUR | -1.47% |
|
-1.88% | -15.16% |
Chart calendar Cellectis S.A.
ea73856e9d530359d8cec4f0894a.O5FzZXWoLmSKxtsi5uSXDLgKRoDJlVvzeXDLapTsvaE.CtU4NBDpTQr5trhWg6_IdPlaE8Ss_TG_Sj2JOPef_-1a2kMSH8sXIM-87w~9f563ed1002b463aabbdd8682b6913a4
Upcoming events on Cellectis S.A.
Past events on Cellectis S.A.
| 24/04/2024 10:15 | The CRISPR MEDiCiNE Conference |
| 08/04/2024 13:40 | GenE-HumDi Meeting |
| 22/12/2023 13:30 | Shareholders Meeting |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Poster No:P4847 |
| 10/12/2023 01:30 | American Society of Hematology Meeting - Poster No:P2110 |
| 06/12/2023 17:00 | JMP Securities Hematology and Oncology Summit |
| 05/12/2023 21:00 | Cell Therapy Analytical Development Summit |
| 28/11/2023 14:10 | Evercore ISI HealthCONx Conference |
| 16/11/2023 08:30 | Jefferies London Healthcare Conference |
| 07/11/2023 13:00 | Q3 2023 Earnings Call |
| 06/11/2023 21:30 | Q3 2023 Earnings Release |
| 05/11/2023 | Bio Europe Conference |
| 04/11/2023 16:00 | Society for Immunotherapy of Cancer Meeting - Poster Number : 254 |
| 25/10/2023 17:15 | European Society of Gene and Cell Therapy Congress - Poster Number 646 |
| 25/10/2023 17:15 | European Society of Gene and Cell Therapy Conference - Poster Number : P464 |
| 25/10/2023 17:15 | European Society of Gene and Cell Therapy Conference - Poster Number : P380 |
| 25/10/2023 16:00 | European Society of Gene and Cell Therapy Conference - Poster Number : P667 |
| 28/08/2023 | CART TCR Summit - Panel |
| 04/08/2023 13:00 | Q2 2023 Earnings Call |
| 03/08/2023 21:30 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 19,1 21,7 -12.01% | 20,6 19,7 4.81% | 68,5 57,6 18.77% | 60,7 55,0 10.31% | 24,5 27,2 -10.08% | 21,5 |
|
EBITDA Million EUR | Released Forecast Spread | -91,0 -92,0 1.07% | -104 -96,6 -8.03% | -62,8 -82,3 23.75% | -111 -115 2.75% | -93,9 -109 14.11% | -38,2 |
|
EBIT Million EUR | Released Forecast Spread | -93,6 -93,0 -0.59% | -111 -108 -2.56% | -70,9 -77,8 8.77% | -118 -127 7.01% | -105 -103 -1.83% | -79,4 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -78,7 -83,5 5.85% | -103 -99,1 -4.46% | -80,9 -83,1 2.6% | -113 -123 8.06% | -108 -104 -3.73% | -71,0 |
|
Net income Million EUR | Released Forecast Spread | -70,1 -79,0 11.27% | -91,7 -95,2 3.67% | -67,3 -76,7 12.23% | -103 -122 14.99% | -100 -98,0 -2.51% | -69,5 |
|
EPS EUR | Released Forecast Spread | -1,71 -2,61 34.56% | -2,16 -3,17 31.75% | -1,59 -2,98 46.85% | -2,31 -3,16 26.91% | -2,21 -3,74 40.99% | 0,00 |
| Announcement Date | 11/03/19 | 04/03/20 | 04/03/21 | 03/03/22 | 08/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 9,38 7,31 28.27% | 12,4 8,51 45.29% | 3,68 16,9 -78.27% | 2,70 25,4 -89.35% | 1,97 19,2 -89.76% | 16,4 20,7 -20.71% | 3,23 5,57 -41.9% | 1,83 4,26 -57.09% | 1,53 3,52 -56.57% | 14,8 | 3,10 | 3,10 | 6,99 | 7,00 |
|
EBITDA Million EUR | Released Forecast Spread | 23,5 | -21,5 | -24,0 | -7,22 | ||||||||||
|
EBIT Million EUR | Released Forecast Spread | -36,7 -34,4 -6.69% | -28,0 -39,9 29.96% | -33,8 -30,4 -11.51% | -33,3 -16,1 -107.53% | -34,0 -23,3 -45.72% | -7,92 -17,9 55.67% | -21,3 -22,1 3.5% | -21,6 -20,9 -3.57% | -19,2 -21,2 9.08% | -14,4 | -21,2 | -22,0 | -17,9 | -19,0 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -34,7 -34,5 -0.52% | -25,4 -37,7 32.67% | -33,4 -20,9 -59.93% | -19,0 -20,1 5.17% | -32,0 -23,9 -33.89% | -26,9 -14,3 -87.99% | -29,6 -18,3 -61.22% | -12,4 -19,7 36.94% | -16,2 -20,7 21.78% | -17,9 | -20,3 | -20,3 | -22,5 | -19,0 |
|
Net income Million EUR | Released Forecast Spread | -32,4 -33,6 3.69% | -22,6 -36,5 38.02% | -30,6 -20,1 -52.41% | -18,5 -18,2 -1.63% | -29,2 -22,1 -31.7% | -25,4 -14,2 -78.29% | -27,3 -17,1 -59.48% | -9,72 -18,1 46.18% | -16,3 -19,2 15.13% | -14,4 | -16,3 | -16,3 | -19,1 | -19,1 |
| Announcement Date | 04/11/21 | 03/03/22 | 12/05/22 | 04/08/22 | 03/11/22 | 08/03/23 | 04/05/23 | 03/08/23 | 06/11/23 | - | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Cellectis S.A.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALCLS Stock
- Calendar Cellectis S.A.
